Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKinsey
US Department of Justice
Dow
Julphar
Federal Trade Commission
Chubb
Teva
Medtronic

Generated: August 17, 2018

DrugPatentWatch Database Preview

Mustafa Nevzat Ilac Company Profile

« Back to Dashboard

What is the competitive landscape for MUSTAFA NEVZAT ILAC, and what generic and branded alternatives to MUSTAFA NEVZAT ILAC drugs are available?

MUSTAFA NEVZAT ILAC has four approved drugs.



Summary for Mustafa Nevzat Ilac

Drugs and US Patents for Mustafa Nevzat Ilac

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mustafa Nevzat Ilac VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 065401-002 Jun 30, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mustafa Nevzat Ilac AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065316-001 Jun 29, 2007 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mustafa Nevzat Ilac FLUDARABINE PHOSPHATE fludarabine phosphate INJECTABLE;INJECTION 090724-001 Sep 27, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mustafa Nevzat Ilac IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 090393-002 May 13, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Argus Health
US Department of Justice
Julphar
Harvard Business School
Cipla
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.